Skip to content

The time for mRNA vaccine equality across the globe

Peter Jensen, CEO and Chairman, Normax delves into why it’s time for mRNA vaccine equality to be established across the globe, how mRNA vaccines can help drive down the cost of vaccines, and support the long-term battle against future pandemics.

The time for mRNA vaccine equality across the globe
Published: | 4 min read

Peter Jensen, CEO and Chairman, Normax delves into why it’s time for mRNA vaccine equality to be established across the globe. He also goes on to explain how mRNA vaccines can help drive down the costs of vaccines, save more lives and support the long-term sustainable battle against future pandemics world-wide.

Key insights:

  • The evolution and spread of viruses is an everlasting accepted phenomenon which must be controlled, for common safety and prosperity.
  • A more affordable and scalable mRNA vaccine strategy is needed to help solve the urgent global demand for effective COVID-19 boosters and other vaccines, save lives, and support innovation and investment in future pandemic prevention.
  • To deal with the threat of future pandemics is to protect everybody everywhere - that means ensuring vaccine equality so that all citizens are in the queue for a potential vaccine.

Three things are certain in life: death, taxes, and pathogens. However, diseases don’t have to be. If post pandemic has shown us anything, pathogens have the power to change our lives forever. It is more important than ever to protect people and animals from infectious diseases as COVID-19 has proven it has no enemies. Thus, resulting in almost 20 million deaths and $28 trillion in economic cost.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information